Memantine Unichem 10 10 mg FC tablets
PDF Leaflet Revision Date: 24 January 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of moderately severe to severe Alzheimer's disease.
Dosage (summary)
Start with 5 mg/day, titrate to 20 mg/day over 4 weeks.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not established; avoid breastfeeding.
Key Drug Interactions
- Avoid NMDA antagonists
- May enhance L-dopa effects
- May reduce barbiturate effects
Contraindications
- Hypersensitivity
- Children under 18
Common side effects
- Confusion
- Dizziness
- Agitation
- Constipation
Counselling Points
- Monitor for CNS effects
- Take at the same time daily
- Avoid driving if affected
Serious warnings
- Not for severe renal impairment
- Caution in patients with convulsions
Important Disclaimer
The Memantine Unichem 10 10 mg FC tablets professional information leaflet below is the property of Unichem Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
